Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial

The aim of this study was to evaluate the efficacy of vilazodone using different definitions of remission. Post-hoc analyses were carried out using data from an 8-week, multicenter, randomized, double-blind, placebo-controlled trial of vilazodone 40 mg/day in adults with major depressive disorder (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Citrome, Leslie, Gommoll, Carl P., Tang, Xiongwen, Nunez, Rene, Mathews, Maju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314104/
https://www.ncbi.nlm.nih.gov/pubmed/25396353
http://dx.doi.org/10.1097/YIC.0000000000000056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314104/
https://www.ncbi.nlm.nih.gov/pubmed/25396353
http://dx.doi.org/10.1097/YIC.0000000000000056

Ejemplares similares